Publications

Below is a list of publications and links to articles, from most recent through 10 years to 2012.

2022

Vaze A, De Angelis RE, Simões M, Arantes TE, Moreto R, Oliver GF, Smith JR, Furtado JM (In press). Optical coherence tomography findings in ocular syphilis involving the posterior segment of the eye. Ocular Immunology and Inflammation. https://doi.org/10.1080/09273948.2021.1892152

Kvopka M, Smith JR, Koczwara B, Lake SR (2022). Bilateral intermediate uveitis following treatment with paclitaxel in a patient with invasive ductal carcinoma of the breast. International Journal of Retina and Vitreous, 8, 63. https://doi.org/10.1186/s40942-022-00415-y

Furtado JM, Smith JR (2022). Authors’ response. Survey of Ophthalmology, 67(5), 1561. https://doi.org/10.1016/j.survophthal.2022.04.005

Robbins SL, Dai S, Smith JR (2022). Eye health for kids. Clinical and Experimental Ophthalmology, 50(6), 587-589. https://doi.org/10.1111/ceo.14135

Ryan FJ, Ma Y, Ashander LM, Kvopka M, Appukuttan B, Lynn DJ, Smith JR (2022). Transcriptomic responses of human retinal vascular endothelial cells to inflammatory cytokines. Translational Vision Science and Technology, 11(8), 27. https://doi.org/10.1167/tvst.11.8.27

Smith JR (2022). Powerful predictors. Clinical and Experimental Ophthalmology, 50(5), 479-480. https://doi.org/10.1111/ceo.14105

Smith JR, Farrall AL, Davis JL, de Boer JH, Hall AJ, Mochizuki M, Sen HN, Takase H, Ten Dam-van Loon NH, Touitou V, Vasconcelos-Santos DV, Wilson DJ, Yeh S, Radford MHB (2022). The International Vitreoretinal B-Cell Lymphoma Registry: a protocol paper. BMJ Open, 12(7), e060701. https://doi.org/10.1136/bmjopen-2021-060701

Agrawal R, Ludi Z, Betzler BK, Testi I, Mahajan S, Rousellot A, Kempen JH, Smith JR, McCluskey P, Nguyen QD, Pavesio C, Gupta V (2022). The Collaborative Ocular Tuberculosis Study (COTS) calculator—a consensus-based decision tool for initiating antitubercular therapy in ocular tuberculosis. Eye. https://doi.org/10.1038/s41433-022-02147-7

Ferreira LB, Furtado JM, Charng J, Franchina M, Matthews JM, Molan AAL, Hunter M, Mackey DA, Smith JR (2022). Prevalence of toxoplasmic retinochoroiditis in an Australian adult population: a community-based study. Ophthalmology Retina. https://doi.org/10.1016/j.oret.2022.04.022

Vaze A, Smith JR, Furtado JM (2022). Re: Hu et al.: Pyramidal inflammatory deposits of the retinal pigment epithelium and outer retina in ocular syphilis (Ophthalmology Retina. 2022;6(2):172-178). Ophthalmology Retina, 6(5), 437. https://doi.org/10.1016/j.oret.2021.12.008

Nguyen AAK, Tsui E, Smith JR (2022). Social media and ophthalmology: a review. Clinical and Experimental Ophthalmology, 50(4), 449-458. https://doi.org/10.1111/ceo.14091

Furtado JM, Simões M, Vasconcelos-Santos D, Oliver GF, Tyagi M, Nascimento H, Gordon DL, Smith JR (2022). Ocular syphilis. Survey of Ophthalmology, 67(2), 440-462. https://doi.org/10.1016/j.survophthal.2021.06.003

Smith JR (2022). A focus on glaucoma. Clinical and Experimental Ophthalmology, 50(2), 123-125. https://doi.org/10.1111/ceo.14053

Ashander LM, Lumsden AL, Dawson AC, Ma Y, Ferreira LB, Appukuttan B, Carr JM, Smith JR, Oliver GF (2022). Infection of human retinal pigment epithelial cells with dengue virus strains isolated during outbreaks in Singapore. Microorganisms, 10(2), 310. https://doi.org/10.3390/microorganisms10020310

Oliver GF, Ferreira LB, Vieira BR, Arruda S, Araújo M, Carr JM, Smith JR, Furtado JM (2022). Posterior segment findings by spectral-domain optical coherence tomography and clinical associations in active toxoplasmic retinochoroiditis. Scientific Reports, 12(1), 1156. https://doi.org/10.1038/s41598-022-05070-9

Ehlers JP, Yeh S, Maguire MG, Smith JR, Mruthyunjaya P, Jain N, Kim LA, Weng CY, Flaxel CJ, Schoenberger SD, Kim SJ (2022). Intravitreal pharmacotherapies for diabetic macular edema: a report by the American Academy of Ophthalmology. Ophthalmology, 129(1), 88-99. https://doi.org/10.1016/j.ophtha.2021.07.009

Betzler BK, Gunasekeran DV, Kempen J, Smith JR, McCluskey P, Nguyen QD, Pavesio C, Gupta V, Agrawal R (2022). The historical evolution of ocular tuberculosis: past, present, and future. Ocular Immunology and Inflammation, 30(3), 593-599. https://doi.org/10.1080/09273948.2021.1992446

2021

Smith JR (2021). Reviewing the reviews. Clinical and Experimental Ophthalmology, 49(9), 995-996. https://doi.org/10.1111/ceo.14003

Gertig D, Keane M, Matthews J, Williams K, Smith J (2021). Women’s authorship of reviews in ophthalmic journals over time. Asia-Pacific Journal of Ophthalmology, 10(6), 590-594. https://doi.org/10.1097/apo.0000000000000444

Takase H, Acharya NR, Babu K, Bodaghi B, Khairallah M, McCluskey PJ, Tesavibul N, Thorne JE, Tugal-Tutkun I, Yamamoto JH, Rao NA, 7th IWOS Study Group, Smith JR, Mochizuki M (2021). Recommendations for the management of ocular sarcoidosis from the International Workshop on Ocular Sarcoidosis. British Journal of Ophthalmology, 105(11), 1515-1519. https://doi.org/10.1136/bjophthalmol-2020-317354

Bradshaw CJA, Chalker JM, Crabtree SA, Eijkelkamp BA, Long JA, Smith JR, Trinajstic K, Weisbecker V (2021). A fairer way to compare researchers at any career stage and in any discipline using open-access citation data. PLoS One, 16(9), e0257141. https://doi.org/10.1371/journal.pone.0257141

Sobolewska B, Chee SP, Zaguia F, Goldstein DA, Smith JR, Fend F, Mochizuki M, Zierhut M (2021). Vitreoretinal lymphoma. Cancers, 13(16), 3921. https://doi.org/10.3390/cancers13163921

The Standardization of Uveitis Nomenclature (SUN) Working Group, Jabs DA, Belfort Jr R,
Bodaghi B, Graham E, Holland GN, Lightman SL, Margolis TP, Oden N, Palestine AG, Smith JR, Thorne JE, Trusko BE, Van Gelder RN (2021). Classification Criteria for Acute Retinal Necrosis Syndrome. American Journal of Ophthalmology, 228, 237-244. https://doi.org/10.1016/j.ajo.2021.03.057

The Standardization of Uveitis Nomenclature (SUN) Working Group, Jabs DA, Belfort Jr R, Bodaghi B, Graham E, Holland GN, Lightman SL, Oden N, Palestine AG, Smith JR, Thorne JE, Trusko BE, Van Gelder RN (2021). Classification Criteria for Cytomegalovirus Retinitis. American Journal of Ophthalmology, 228, 245-254. https://doi.org/10.1016/j.ajo.2021.03.051

The Standardization of Uveitis Nomenclature (SUN) Working Group, Jabs DA, Belfort Jr R, Bodaghi B, Graham E, Holland GN, Lightman SL, Oden N, Palestine AG, Smith JR, Thorne JE, Trusko BE (2021). Classification Criteria for Syphilitic Uveitis. American Journal of Ophthalmology, 228, 182-191. https://doi.org/10.1016/j.ajo.2021.03.039

The Standardization of Uveitis Nomenclature (SUN) Working Group, Jabs DA, Belfort Jr R, Bodaghi B, Graham E, Holland GN, Lightman SL, Oden N, Palestine AG, Smith JR, Thorne JE, Trusko BE (2021). Classification Criteria for Toxoplasmic Retinitis. American Journal of Ophthalmology, 228, 134-141. https://doi.org/10.1016/j.ajo.2021.03.042

The Standardization of Uveitis Nomenclature (SUN) Working Group, Jabs DA, Belfort Jr R, Bodaghi B, Graham E, Gupta V, Holland GN, Lightman SL, Oden N, Palestine AG, Smith JR, Thorne JE, Trusko BE (2021). Classification Criteria for Tubercular Uveitis. American Journal of Ophthalmology, 228, 142-151. https://doi.org/10.1016/j.ajo.2021.03.040

The Standardization of Uveitis Nomenclature (SUN) Working Group (2021). Development of Classification Criteria for the Uveitides. American Journal of Ophthalmology, 228, 96-105. https://doi.org/10.1016/j.ajo.2021.03.061

Tallouzi MO, Mathers JM, Moore DJ, Bucknall N, Calvert MJ, Murray PI, Denniston AK, COSUMO Working Group, Smith J (2021). Development of a core outcome set for clinical trials in non-infectious uveitis of the posterior segment. Ophthalmology, 128(8), 1209-1221. https://doi.org/10.1016/j.ophtha.2021.01.022

Smith JR (2021). Having impact. Clinical and Experimental Ophthalmology, 49(6), 537-539. https://doi.org/10.1111/ceo.13968

Cunningham ET, Miserocchi E, Smith JR, Gonzales JA, Zierhut M (2021). Intraocular lymphoma. Ocular Immunology and Inflammation, 29(3), 425-429. https://doi.org/10.1080/09273948.2021.1941684

Agrawal R, Testi I, Lee CS, Tsui E, Blazes M, Thorne JE, Okada AA, Smith JR, McCluskey PJ, Kempen JH, Tappeiner C, Agarwal M, Bodaghi B, Nguyen QD, Gupta V, De Smet MD, Zierhut M, Pavesio C, COVID-19 IMT for NIU Study Group (2021). Evolving consensus for immunomodulatory therapy in non-infectious uveitis during the COVID-19 pandemic. British Journal of Ophthalmology, 105(5), 639-647. https://doi.org/10.1136/bjophthalmol-2020-316776

Ryan FJ, Carr JM, Furtado JM, Ma Y, Ashander LM, Simões M, Oliver GF, Granado GB, Dawson AC, Michael MZ, Appukuttan B, Lynn DJ, Smith JR (2021). Zika virus infection of human iris pigment epithelial cells. Frontiers in Immunology, 12, 644153. https://doi.org/10.3389/fimmu.2021.644153

Smith JR (2021). Ophthalmology Letterbox. Clinical and Experimental Ophthalmology, 49, 225-227. https://doi.org/10.1111/ceo.13908

Mallett JJ, Chin DL, Rush IM, Smith JR (2021). The transition of ARVO journals to open access. Learned Publishing, 34(2), 262-271. https://doi.org/10.1002/leap.1338

Thng ZX, De Smet MD, Lee CS, Gupta V, Smith JR, McCluskey PJ, Thorne JE, Kempen JH, Zierhut M, Nguyen QD, Pavesio C, Agrawal R (2021). COVID-19 and immunosuppression: A review of current clinical experiences and implications for ophthalmology patients taking immunosuppressive drugs. British Journal of Ophthalmology, 105(3), 306-310.  https://doi.org/10.1136/bjophthalmol-2020-316586

Smith JR, Ashander LM, Arruda SL, Cordeiro CA, Lie S, Rochet E, Belfort R, Furtado JM (2021). Pathogenesis of ocular toxoplasmosis. Progress in Retinal and Eye Research, 81, 100882. https://doi.org/10.1016/j.preteyeres.2020.100882

Arruda S, Vieira BR, Garcia DM, Araújo M, Simões M, Moreto R, Rodrigues MW, Belfort R, Smith JR, Furtado JM (2021). Clinical manifestations and visual outcomes associated with ocular toxoplasmosis in a Brazilian population. Scientific Reports, 11(1), [3137]. https://doi.org/10.1038/s41598-021-82830-z

Agrawal R, Testi I, Mahajan S, Yuen YS, Agarwal A, Kon OM, Barisani-Asenbauer T, Kempen J, Gupta A, Jabs DA, Smith J, Nguyen QD, Pavesio C, Gupta V (2021). Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis—Report 1: Guidelines for Initiating Antitubercular Therapy in Tubercular Choroiditis. Ophthalmology, 128(2), 266-276. https://doi.org/10.1016/j.ophtha.2020.01.008

Agrawal R, Testi I, Bodaghi B, Barisani-Asenbauer T, McCluskey P, Agarwal A, Kempen JH, Gupta A, Smith JR, de Smet MD, Yuen YS, Mahajan S, Kon OM, Nguyen QD, Pavesio C, Gupta V, Collaborative Ocular Tuberculosis Study Consensus Group (2021). Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis—Report 2: Guidelines for Initiating Antitubercular Therapy in Anterior Uveitis, Intermediate Uveitis, Panuveitis, and Retinal Vasculitis. Ophthalmology, 128(2), 277-287. https://doi.org/10.1016/j.ophtha.2020.06.052

Farrall AL, Smith JR (2021). Changing incidence and survival of primary central nervous system lymphoma in Australia: A 33-year national population-based study. Cancers, 13(3), [403]. https://doi.org/10.3390/cancers13030403

Ferreira LB, Smith AJ, Smith JR (2021). Biologic drugs for the treatment of noninfectious uveitis. Asia-Pacific Journal of Ophthalmology, 10(1), 63-73. https://doi.org/10.1097/APO.0000000000000371

Smith JR, Matthews JM, Conrad D, Hall AJ, Tay-Kearney ML, Wells J, Zagora SL, Australian and New Zealand Juvenile Idiopathic Arthritis-Uveitis Working Group, McCluskey PJ (2021). Recommendations for the management of childhood juvenile idiopathic arthritis-type chronic anterior uveitis. Clinical & Experimental Ophthalmology, 49(1), 38-45. https://doi.org/10.1111/ceo.13856

Carbonell D, Mahajan S, Chee S-P, Sobolewska B, Agrawal R, Bülow T, Gupta V, Jones NP, Accorinti M, Agarwal M, Batchelor T, Biswas J, Cimino L, tenDam-van Loon NH, de-la-Torre A, Frenkel S, Pe’er J, Kramer M, Miserocchi E, Mochizuki M, Ness T, Rosenbaum JT, Sen HN, Simion M, Sitter H, Vasconcelos-Santos D, Habot-Wilner Z, Coupland SE, Pulido JS, Smith J, Thorne JE, Study Group for Vitreoretinal Lymphoma Diagnostics, Zierhut M (2021). Consensus Recommendations for the Diagnosis of Vitreoretinal Lymphoma. Ocular Immunology and Inflammation, 29(3), 507-520. https://doi.org/10.1080/09273948.2021.1878233

Steffen J, Coupland SE, Smith JR (2021). Primary vitreoretinal lymphoma in HIV infection. Ocular Immunology and Inflammation, 29(3), 621-627. https://doi.org/10.1080/09273948.2020.1751856

Ferreira LB, Farrall AL, Furtado JM, Smith JR (2021). Treatment of noninfectious uveitis. Arquivos Brasileiros de Oftalmologia, 84(6), 610-621. https://doi.org/10.5935/0004-2749.20220094

2020

Napier RJ, Lee EJ, Davey MP, Vance EE, Furtado JM, Snow PE, Samson KA, Lashley SJ, Brown BR, Horai R, Mattapallil MJ, Xu B, Callegan MC, Uebelhoer LS, Lancioni CL, Vehe RK, Binstadt BA, Smith JR, Caspi RR, Rosenzweig HL (2020). T cell-intrinsic role for Nod2 in protection against Th17-mediated uveitis. Nature Communications, 11(1), [5406]. https://doi.org/10.1038/s41467-020-18961-0

Gertig D, Smith JR (2020). Screening and avoidance of blindness: one cannot exist without the other. Clinical and Experimental Ophthalmology, 48(9), 1133-1135. https://doi.org/10.1111/ceo.13881

Smith JR (2020). Translational research in ophthalmology. Clinical and Experimental Ophthalmology, 48(8), 1027-1028. https://doi.org/10.1111/ceo.13870

Smith JR (2020). The imaging revolution. Clinical and Experimental Ophthalmology, 48(7), 873-874. https://doi.org/10.1111/ceo.13822

Mallett JJ, Chin DL, Rush IM, Smith JR. (2020). The transition of ARVO journals to open access. Learned Publishing. https://doi.org/10.1002/leap.1338

Takase H, Acharya NR, Babu K, Bodaghi B, Khairallah M, Mccluskey PJ, Tesavibul N, Thorne JE, Tugal-Tutkun I, Yamamoto JH, Rao NA, 7th IWOS Study Group, Smith JR, Mochizuki M (2020). Recommendations for the management of ocular sarcoidosis from the International Workshop on Ocular Sarcoidosis. British Journal of Ophthalmology, [317354]. https://doi.org/10.1136/bjophthalmol-2020-317354

Farrall AL, Smith JR (2020). Eye involvement in primary central nervous system lymphoma. Survey of Ophthalmology, 65(5), 548-561. https://doi.org/10.1016/j.survophthal.2020.02.001

Smith JR, Lai TYY (2020). Managing uveitis during the COVID-19 pandemic. Ophthalmology, 127(9), e65-e67. https://doi.org/10.1016/j.ophtha.2020.05.037

Basu S, La Distia Nora R, Rao NA, Jiang X, Fuady A, International Ocular TB Study group [including Smith JR] (2020). Prognostic factors for TB-associated uveitis in the Asia-Pacific Region: results of a modified Delphi survey. Eye, 34(9), 1693-1701. https://doi.org/10.1038/s41433-019-0743-1

Galanopoulous A, Smith JR (2020). Vitamins for glaucoma. Clinical and Experimental Ophthlamology, 48(7), 877-878. https://doi.org/10.1111/ceo.13849

Sadhu S, Agrawal R, Pyare R, Pavesio C, Zierhut M, Khatri A, Smith JR, de Smet MD, Biswas J (2020). COVID-19: limiting the risks for eye care professionals. Ocular Immunology and Inflammation, 28(5), 714-720. https://doi.org/10.1080/09273948.2020.1755442

Thng ZX, De Smet MD, Lee CS, Gupta V, Smith JR, McCluskey PJ, Thorne JE, Kempen JH, Zierhut M, Nguyen QD, Pavesio C, Agrawal R (2020). COVID-19 and immunosuppression: a review of current clinical experiences and implications for ophthalmology patients taking immunosuppressive drugs. British Journal of Ophthalmology, [316586]. https://doi.org/10.1136/bjophthalmol-2020-316586

Steffen J, Coupland SE, Smith JR (2020). Primary vitreoretinal lymphoma in HIV infection. Ocular Immunology and Inflammation. https://doi.org/10.1080/09273948.2020.1751856

Smith JR (2020). Vision in 2020 for Clinical and Experimental Ophthalmology. Clinical and Experimental Ophthalmology, 48(3), 285-286. https://doi.org/10.1111/ceo.13746

Agrawal R, et. al. [91 co-authors including JR Smith, members of Collaborative Ocular Tuberculosis Study (COTS) Group] (2020). Standardization of nomenclature for ocular tuberculosis: results of Collaborative Ocular Tuberculosis Study (COTS) workshop. Ocular Immunology and Inflammation, 28(S1), 74-84. https://doi.org/10.1080/09273948.2019.1653933

The Collaborative Ocular Tuberculosis Study Group, Smith JR (2020). The Collaborative Ocular Tuberculosis Study (COTS) Consensus (CON) Group Meeting Proceedings. Ocular Immunology and Inflammation, 28(S1), 85-95. https://doi.org/10.1080/09273948.2020.1716025

Kvopka M, Lake S, Smith J (2020). Intraocular chemotherapy for vitreoretinal lymphoma: a review. Clinical and Experimental Ophthlamology, 48(2), 240-248. https://doi.org/10.1111/ceo.13668

Dawson AC, Ashander LM, Appukuttan B, Woodman RJ, Dubey JP, Whiley H, Smith JR (2020). Lamb as a potential source of Toxoplasma gondii infection for Australians. Australian and New Zealand Journal of Public Health, 44(1), 49-52. https://doi.org/10.1111/1753-6405.12955

Norbury AJ, Calvert JK, Al-Shujairi WH, Cabezas-Falcon S, Tang V, Ong LC, Alonso SL, Smith JR, Carr JM (2020). Dengue virus infects the mouse eye following systemic or intracranial infection and induces inflammatory responses. Journal of General Virology, 101(1), 79-85. https://doi.org/10.1099/jgv.0.001354

Smith JR, Ashander LM, Ma Y, Rochet E, Furtado JM (2020). Model systems for studying mechanisms of ocular toxoplasmosis. In CJ Tonkin (Ed), Toxoplasma gondii: Methods and Protocols (pp. 297-321). (Methods in Molecular Biology; Vol. 2071). Humana Press Inc. https://doi.org/10.1007/978-1-4939-9857-9_17

Booth AEC, Hopkins AM, Rowland A, Kichenadasse G, Smith JR, Sorich MJ (2020). Risk factors for MEK-associated retinopathy in patients with advanced melanoma treated with combination BRAF and MEK inhibitor therapy. Therapeutic Advances in Medical Oncology, 12, 1-10. https://doi.org/10.1177/1758835920944359

Radosavljevic A, Agarwal M, Bodaghi B, Smith JR, Zierhut M (2020). Medical therapy of uveitic macular edema: biologic agents. Ocular Immunology and Inflammation, 28(8), 1239-1250. https://doi.org/10.1080/09273948.2019.1709648

2019

Oliver G, Stathis R, Fortes Furtado J, Arantes T, McCluskey P, Matthews JM, International Ocular Syphilis Study Group, Smith J (2019). Current ophthalmology practice patterns for syphilitic uveitis. British Journal of Ophthalmology, 103(11), 1645-1649. https://doi.org/10.1136/bjophthalmol-2018-313207

Ashander LM, Lie S, Ma Y, Rochet E, Washington JM, Furtado JM, Appukuttan B, Smith JR (2019). Neutrophil activities in human ocular toxoplasmosis: an in vitro study with human cells. Investigative Ophthalmology & Visual Science, 60(14), 4652-4660. https://doi.org/10.1167/iovs.19-28306

Oliver G, Valinezhad Orang A, Appukuttan B, Marri S, Michael M, Marsh G, Smith J (2019). Expression of microRNA in human retinal pigment epithelial cells following infection with Zaire ebolavirus. BMC Research Notes, 12(639), [639]. https://doi.org/10.1186/s13104-019-4671-8

Lie S, Vieira BR, Arruda S, Simões M, Ashander LM, Furtado JM, Smith JR (2019). Molecular basis of the retinal pigment epithelial changes that characterize the ocular lesion in toxoplasmosis. Microorganisms, 7(10), [405]. https://doi.org/10.3390/microorganisms7100405

Rochet E, Appukuttan B, Ma Y, Ashander L, Smith J (2019). Expression of long non-coding RNAs by human retinal Müller glial cells infected with clonal and exotic virulent Toxoplasma gondii. Non-coding RNA, 5(4), [48]. https://doi.org/10.3390/ncrna5040048

Lie S, Rochet E, Segerdell E, Ma Y, Ashander LM, Shadforth AMA, Blenkinsop TA, Michael MZ, Appukuttan B, Wilmot B, Smith JR (2019). Immunological molecular responses of human retinal pigment epithelial cells to infection with Toxoplasma gondii. Frontiers in Immunology, 10. https://doi.org/10.3389/fimmu.2019.00708

Oliver GF, Carr JM, Smith JR (2019). Emerging infectious uveitis: Chikungunya, dengue, Zika and Ebola: a review. Clinical and Experimental Ophthalmology, 47(3), 372-380. https://doi.org/10.1111/ceo.13450

Crawford LC, Smith JR (2019). Taking care to correctly diagnose viral anterior uveitis. Clinical and Experimental Ophthalmology, 47(3), 317-319. https://doi.org/10.1111/ceo.13509

Accorinti M, Okada AA, Smith JR, Gilardi M (2019). Epidemiology of macular edema in uveitis. Ocular Immunology and Inflammation, 27(2), 169-180. https://doi.org/10.1080/09273948.2019.1576910

Smith JR, Pe’er J, Belfort RN, Cardoso F, Carvajal RD, Carvalho C, Coupland SE, Desjardins L, Francis JH, Gallie BL, Gombos D, Grossniklaus HE, Heegaard S, Jager MJ, Kaliki S, Ksander B, Maeurer M, Moreno E, Pulido JS, Ryll B, Singh AD, Zhao J, Parreira A, Wilson DJ, O’brien JM (2019). Proceedings of the Association for Research in Vision and Ophthalmology and Champalimaud Foundation Ocular Oncogenesis and Oncology Conference. Translational Vision Science and Technology, 8(1), [9]. https://doi.org/10.1167/tvst.8.1.9

Mochizuki M, Smith JR, Takase H, Kaburaki T, Acharya NR, Rao NA, International Workshop on Ocular Sarcoidosis Study Group (2019). Revised criteria of International Workshop on Ocular Sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis. British Journal of Ophthalmology, 103(10), 1418-1422. https://doi.org/10.1136/bjophthalmol-2018-313356

2018

Dawson A, Williams K, Appukuttan B, Smith J (2018). Emerging diagnostic tests for vitreoretinal lymphoma: a review. Clinical and Experimental Ophthalmology, 46(8), 945-954. https://doi.org/10.1111/ceo.13304

Furtado J, Arantes T, Nascimento H, Vasconcelos-Santos D, Nogueira N, de Pinho Queiroz R, Brandão L, Bastos T, Martinelli R, Santana R, Muccioli C, Belfort R, Smith J (2018). Clinical manifestations and ophthalmic outcomes of ocular syphilis at a time of re-emergence of the systemic infection. Scientific Reports, 8(1), [12071]. https://doi.org/10.1038/s41598-018-30559-7

Furtado JM, Arantes TE, Nascimento H, Vasconcelos-Santos DV, Nogueira N, Queiroz RDP, Brandão LP, Bastos T, Martinelli R, Santana RC, Muccioli C, Belfort R, Smith JR (2018). Author Correction: Clinical manifestations and ophthalmic outcomes of ocular syphilis at a time of re-emergence of the systemic infection (Scientific Reports, 2018, 8(1), [12071]). Scientific Reports, 8(1), [15902]. https://doi.org/10.1038/s41598-018-34170-8

Yeh S, Shantha J, Hayek B, Crozier I, Smith J (2018). Clinical manifestations and pathogenesis of uveitis in Ebola virus disease survivors. Ocular Immunology and Inflammation, 26(7), 1128-1134. https://doi.org/10.1080/09273948.2018.1484493

Smith JR, David LL, Appukuttan B, Wilmarth PA (2018). Angiogenic and immunologic proteins identified by deep proteomic profiling of human retinal and choroidal vascular endothelial cells: potential targets for new biologic drugs. American Journal of Ophthalmology, 193, 197-229. https://doi.org/10.1016/j.ajo.2018.03.020

Appukuttan B, Ma Y, Stempel A, Ashander L, Deliyanti D, Wilkinson-Berka J, Smith J (2018). Effect of NADPH oxidase 1 and 4 blockade in activated human retinal endothelial cells. Clinical and Experimental Ophthalmology, 46(6), 652-660. https://doi.org/10.1111/ceo.13155

Cabezas S, Bracho Granado G, Aloia A, Adamson PJ, Bonder CS, Smith JR, Gordon DL, Carr JM (2018). Dengue virus induces increased activity of the complement alternative pathway in infected cells. Journal of Virology, 92(14), [e00633-18]. https://doi.org/10.1128/JVI.00633-18

Lumsden AL, Ma Y, Ashander LM, Stempel AJ, Keating DJ, Smith JR, Appukuttan B (2018). ICAM-1-related long non-coding RNA: promoter analysis and expression in human retinal endothelial cells. BMC Research Notes, 11(1), [285]. https://doi.org/10.1186/s13104-018-3384-8

Appukuttan B, Ashander L, Ma Y, Smith J (2018). Selection of reference genes for studies of human retinal endothelial cell gene expression by reverse transcription-quantitative real-time polymerase chain reaction. Gene Reports, 10, 123-134. https://doi.org/10.1016/j.genrep.2017.11.009

Jabs DA, Dick A, Doucette JT, Gupta A, Lightman S, McCluskey P, Okada AA, Palestine AG, Rosenbaum JT, Saleem SM, Thorne J, Trusko B, Standardization of Uveitis Nomenclature (SUN) Working Group [inc. Smith JR] (2018). Interobserver agreement among uveitis experts on uveitic diagnoses: the Standardization of Uveitis Nomenclature experience. American Journal of Ophthalmology, 186, 19-24. https://doi.org/10.1016/j.ajo.2017.10.028

Smith JR (2018). Association of cataract surgery with decreased mortality among US women. JAMA Ophthalmology, 136(1), 10-11. https://doi.org/10.1001/jamaophthalmol.2017.4581

2017

Brown B, Lee E, Snow P, Vance E, Iwakura Y, Ohno N, Miura N, Lin X, Brown G, Wells C, Smith J, Caspi R, Rosenzweig H (2017). Fungal-derived cues promote ocular autoimmunity through a Dectin-2/Card9-mediated mechanism. Clinical and Experimental Immunology, 190(3), 293-303. https://doi.org/10.1111/cei.13021

Reddy AK, Smith JR, Thorne JE (2017). Medicare billing and reimbursement differ for women and men in ophthalmology—reply. JAMA Ophthalmology, 135(9), 1006-1006. https://doi.org/10.1001/jamaophthalmol.2017.2785

Oliver G, Stathis R, Spurrier N, Smith J (2017). Use of Standardization of Uveitis Nomenclature for reporting clinical data at 10 years. Ophthalmology, 124(7), 1084-1085. https://doi.org/10.1016/j.ophtha.2017.03.009

Reddy A, Bounds G, Bakri S, Gordon L, Smith J, Haller J, Berrocal A, Thorne J (2017). Differences in clinical activity and medicare payments for female vs male ophthalmologists. JAMA Ophthalmology, 135(3), 205-213. https://doi.org/10.1001/jamaophthalmol.2016.5399

Wakefield D, McCluskey P, Wildner G, Thurau S, Carr G, Chee S-P, Forrester J, Dick A, Hudson B, Lightman S, Smith J, Tugal-Tutkun I (2017). Inflammatory eye disease: pre-treatment assessment of patients prior to commencing immunosuppressive and biologic therapy: recommendations from an expert committee. Autoimmunity Reviews, 16(3), 213-222. https://doi.org/10.1016/j.autrev.2017.01.003

Groen-Hakan F, Babu K, Tugal-Tutkun I, Pathanapithoon K, De Boer J, Smith J, de Groot-Mijnes J, Rothova A (2017). Challenges of diagnosing viral anterior uveitis. Ocular Immunology and Inflammation, 25(5), 715-725. https://doi.org/10.1080/09273948.2017.1353105

Carr J, Ashander L, Calvert J, Ma Y, Aloia A, Bracho G, Chee S-P, Appukuttan B, Smith JR (2017). Molecular responses of human retinal cells to infection with Dengue Virus. Mediators of Inflammation, 2017, [3164375]. https://doi.org/10.1155/2017/3164375 [Erratum https://doi.org/10.1155/2018/9891049]

Bharadwaj A, Stempel A, Olivas A, Franzese S, Ashander L, Ma Y, Lie S, Appukuttan B, Smith J (2017). Molecular signals involved in human B cell migration into the retina: in vitro investigation of ICAM-1, VCAM-1, and CXCL13. Ocular Immunology and Inflammation, 25(6), 811-819. https://doi.org/10.1080/09273948.2016.1180401

Smith J, Todd S, Ashander L, Charitou T, Ma Y, Yeh S, Crozier I, Michael M, Appukuttan B, Williams K, Lynn D, Marsh G (2017). Retinal pigment epithelial cells are a potential reservoir for Ebola virus in the human eye. Translational Vision Science & Technology, 6(4), [12]. https://doi.org/10.1167/tvst.6.4.12

2016

Cunningham E, Smith J, Tugal-Tutkun I, Rothova A, Zierhut M (2016). Uveitis in children and adolescents. Ocular Immunology and Inflammation, 24(4), 365-371. https://doi.org/10.1080/09273948.2016.1204777

Smith JR, Stempel AJ, Bharadwaj A, Appukuttan B (2016). Involvement of B cells in non-infectious uveitis. Clinical & Translational Immunology, 5(2), [e63]. https://doi.org/10.1038/cti.2016.2

Smith JR (2016). Azathioprine. In M Zierhut, C Pavesio, S Ohno, F Orefice, NA Rao (Eds), Intraocular Inflammation (pp. 309-314). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-540-75387-2_22

Shantha J, Crozier I, Varkey JB, Kraft CS, Lyon GM III, Mehta A, Carlson RD, Hill CE, Kumar G, Debiec MR, Patel PS, Olsen TW, Nussenblatt RB, Martin DF, Stroher U, Uyeki TM, Ribner BS, Smith J, Yeh S (2016). Long-term management of panuveitis and iris heterochromia in an Ebola survivor. Ophthalmology, 123(12), 2626-2628.e2. https://doi.org/10.1016/j.ophtha.2016.07.013

Reddy A, Bounds G, Bakri S, Gordon L, Smith J, Haller J, Thorne J (2016). Representation of women with industry ties in ophthalmology. Archives of Ophthalmology, 134(6), 636-643. https://doi.org/10.1001/jamaophthalmol.2016.0552

Ashander L, Appukuttan B, Ma Y, Gardner-Stephen D, Smith J (2016). Targeting endothelial adhesion molecule transcription for treatment of inflammatory disease: a proof-of-concept study. Mediators of Inflammation, 2016, [7945848]. https://doi.org/10.1155/2016/7945848

Smith J, Zierhut M (2016). Thromboangiitis Obliterans. In M Zierhut, C Pavesio, S Ohno, F Orefice, & NA Rao (Eds), Intraocular Inflammation (pp. 773-776). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-540-75387-2_63

2015

Wells JM, Smith JR (2015). Uveitis in juvenile idiopathic arthritis: recent therapeutic advances. Ophthalmic Research, 54(3), 124-127. https://doi.org/10.1159/000438758

Varkey J, Shantha J, Crozier I, Kraft C, Lyon G, Mehta A, Kumar G, Smith J, Kainulainen M, Whitmer S, Stroher U, Uyeki T, Ribner B, Yeh S (2015). Persistence of Ebola virus in ocular fluid during convalescence. New England Journal of Medicine, 372(25), 2423-2427. https://doi.org/10.1056/NEJMoa1500306

Faridi A, Yeh S, Suhler E, Smith J, Flaxel C (2015). Retinal detachment associated with ocular toxoplasmosis. Retina, 35(2), 358-363. https://doi.org/10.1097/IAE.0000000000000279

Stempel A, Appukuttan B, Smith J (2015). Detection of CXCL13 transcript in hepatitis C virus-associated mixed cryoglobulinemia. Blood.

Pan Y, Appukuttan B, Mohs K, Ashander L, Smith J (2015). Ubiquitin carboxyl-terminal esterase L1 promotes proliferation of human choroidal and retinal endothelial cells. Asia-Pacific Journal of Ophthalmology, 4(1), 51-55. https://doi.org/10.1097/APO.0000000000000109

Wells J, Smith J (2015). Uveitis in human immunodeficiency virus–infected individuals. International Ophthalmology Clinics, 55(2), 11-18. https://doi.org/10.1097/IIO.0000000000000061

2014

Suhler E, Lim L, Beardsley R, Giles T, Pasadhika S, Lee S, de Saint Sardos A, Butler N, Smith J, Rosenbaum J (2014). Rituximab therapy for refractory scleritis: results of a phase I/II dose-ranging randomized, clinical trial. Ophthalmology, 121(10), 1885-1891. https://doi.org/10.1016/j.ophtha.2014.04.044

Yeh S, Suhler E, Smith J, Bruce B, Fahle G, Bailey S, Hwang T, Stout J, Lauer A, Wilson D, Rosenbaum J, Flaxel C (2014). Combination systemic and intravitreal antiviral therapy in the management of acute retinal necrosis syndrome. Ophthalmic Surgery, Lasers and Imaging Retina, 45(5), 399-407. https://doi.org/10.3928/23258160-20140908-02

Wells J, Smith J (2014). Riding the wave: challenges in the management of serpiginous choroiditis. Clinical and Experimental Ophthalmology, 42(7), 601-602. https://doi.org/10.1111/ceo.12411

Suhler E, Lim L, Beardsley R, Giles T, Pasadhika S, Lee S, de Saint Sardos A, Butler N, Smith J, Rosenbaum J (2014). Rituximab therapy for refractory orbital inflammation results of a phase 1/2, dose-ranging, randomized clinical trial. JAMA Ophthalmology, 132(5), 572-578. https://doi.org/10.1001/jamaophthalmol.2013.8179

Larkin K, Saboo U, Comer G, Forooghian F, MacKensen F, Merrill P, Sen H, Singh A, Essex R, Lake S, Lim L, Vasconcelos-Santos D, Foster C, Wilson D, Smith J (2014). Use of intravitreal rituximab for treatment of vitreoretinal lymphoma. British Journal of Ophthalmology, 98(1), 99-103. https://doi.org/10.1136/bjophthalmol-2013-304043

Rose-Nussbaumer J, Goldstein D, Thorne J, Arantes T, Acharya N, Shakoor A, Jeng B, Yeh S, Rahman H, Vemulakonda G, Flaxel C, West S, Holland G, Smith J (2014). Uveitis in human immunodeficiency virus-infected persons with CD4+ T-lymphocyte count over 200 cells/mL. Clinical and Experimental Ophthalmology, 42(2), 118-125. https://doi.org/10.1111/ceo.12141

2013

Lee S, Gupta S, Richards A, Suhler E, Smith J, Flaxel C (2013). The use of vascular endothelial growth factor inhibitor for choroidal neovascularization complicating posterior uveitis in eyes with fluocinolone acetonide implants. Retinal Cases & Brief Reports, 7(1), 35-40. https://doi.org/10.1097/ICB.0b013e31825d8152

Bharadwaj A, Schewitz-Bowers L, Wei L, Lee R, Smith J (2013). Intercellular adhesion molecule 1 mediates migration of Th1 and Th17 cells across human retinal vascular endothelium. Investigative Ophthalmology and Visual Science, 54(10), 6917-6925. https://doi.org/10.1167/iovs.13-12058

Suhler E, Lowder C, Goldstein D, Giles T, Lauer A, Kurz P, Pasadhika S, Lee S, de Saint Sardos A, Butler N, Tessler H, Smith J, Rosenbaum J (2013). Adalimumab therapy for refractory uveitis: results of a multicentre, open-label, prospective trial. British Journal of Ophthalmology, 97(4), 481-486. https://doi.org/10.1136/bjophthalmol-2012-302292

Chipps T, Appukuttan B, Pan Y, Smith J (2013). CD44 isoforms in human retinal and choroidal endothelial cells. Graefe’s Archive For Clinical and Experimental Ophthalmology, 251(4), 1245-1246. https://doi.org/10.1007/s00417-012-2103-8

Furtado J, Ashander L, Mohs K, Chipps T, Appukuttan B, Smith J (2013). Toxoplasma gondii migration within and infection of human retina. PLoS One, 8(2), e54358.  https://doi.org/10.1371/journal.pone.0054358

Butler N, Furtado J, Winthrop K, Smith J (2013). Ocular toxoplasmosis II: clinical features, pathology and management. Clinical and Experimental Ophthalmology, 41(1), 95-108. https://doi.org/10.1111/j.1442-9071.2012.02838.x

Furtado J, Winthrop K, Butler N, Smith J (2013). Ocular toxoplasmosis I: parasitology, epidemiology and public health. Clinical and Experimental Ophthalmology, 41(1), 82-94. https://doi.org/10.1111/j.1442-9071.2012.02821.x

Bharadwaj A, Appukuttan B, Wilmarth P, Pan Y, Stempel A, Chipps T, Benedetti E, Zamora D, Choi D, David L, Smith J (2013). Role of the retinal vascular endothelial cell in ocular disease. Progress in Retinal and Eye Research, 32(1), 102-180. https://doi.org/10.1016/j.preteyeres.2012.08.004

Rosenbaum J, Smith J (2013). Immunologic ocular disease. In Clinical Immunology: Principles and Practice: Fourth Edition (4th ed ed., pp. 885-895). Elsevier-Saunders. https://doi.org/10.1016/B978-0-7234-3691-1.00087-8

2012

Simmons-Rear A, Yeh S, Chan-Kai B, Lauer A, Flaxel C, Smith J, Rosenbaum J, Suhler E (2012). Characterization of serous retinal detachments in uveitis patients with optical coherence tomography. Journal of Ophthalmic Inflammation and Infection, 2(4), 191-197. https://doi.org/10.1007/s12348-012-0084-8

Davis E, Rathinam S, Okada A, Tow S, Petrushkin H, Graham E, Chee S, Guex-Crosier Y, Jakob E, Tugal-Tutkun I, Cunningham E, Leavitt J, Mansour A, Winthrop K, Hills W, Smith J (2012). Clinical spectrum of tuberculous optic neuropathy. Journal of Ophthalmic Inflammation and Infection, 2(4), 183-189. https://doi.org/10.1007/s12348-012-0079-5

Smith J, Chipps T, Ilias H, Pan Y, Appukuttan B (2012). Expression and regulation of activated leukocyte cell adhesion molecule in human retinal vascular endothelial cells. Experimental Eye Research, 104, 89-93. https://doi.org/10.1016/j.exer.2012.08.006

Ramkumar H, Shen D, Tuo J, Braziel R, Coupland S, Smith J, Chan C (2012). IL-10-1082 SNP and IL-10 in primary CNS and vitreoretinal lymphomas. Graefe’s Archive For Clinical and Experimental Ophthalmology, 250(10), 1541-1548. https://doi.org/10.1007/s00417-012-2037-1

Furtado J, Bharadwaj A, Ashander L, Olivas A, Smith J (2012). Migration of Toxoplasma gondii-infected dendritic cells across human retinal vascular endothelium. Investigative Ophthalmology and Visual Science, 53(11), 6856-6862. https://doi.org/10.1167/iovs.12-10384

Furtado J, Bharadwaj A, Chipps T, Pan Y, Ashander L, Smith J (2012). Toxoplasma gondii tachyzoites cross retinal endothelium assisted by intercellular adhesion molecule-1 in vitro. Immunology and Cell Biology, 90(9), 912-915. https://doi.org/10.1038/icb.2012.21

Heiligenhaus A, Foeldvari I, Edelsten C, Smith J, Saurenmann R, Bodaghi B, De Boer J, Graham E, Anton J, Kotaniemi K, MacKensen F, Minden K, Nielsen S, Rabinovich E, Ramanan A, Strand V (2012). Proposed outcome measures for prospective clinical trials in juvenile idiopathic arthritis-associated uveitis: a consensus effort from the multinational interdisciplinary working group for uveitis in childhood. Arthritis Care and Research, 64(9), 1365-1372. https://doi.org/10.1002/acr.21674

Appukuttan B, McFarland T, Stempel A, Kassem J, Hartzell M, Zhang Y, Bond D, West K, Wilson R, Stout A, Pan Y, Ilias H, Robertson K, Klein M, Wilson D, Smith J, Stout J (2012). The related transcriptional enhancer factor-1 isoform, TEAD4216, can repress vascular endothelial growth factor expression in mammalian cells. PLoS One, 7(6), e31260. https://doi.org/10.1371/journal.pone.0031260

Smith JR, Jabs DA, Van Gelder RN (2012). Uveitis is a subspeciality: Letter to the Editor. General correspondence. Ophthalmology, 119(4), 887-888. https://doi.org/10.1016/j.ophtha.2011.11.017

Butler N, Smith J (2012). Imaging in the diagnosis and management of acute zonal occult outer retinopathy. International Ophthalmology Clinics, 52(4), 257-261. https://doi.org/10.1097/IIO.0b013e318265d3fd

Furtado J, Davies M, Choi D, Lauer A, Appukuttan B, Bailey S, Rahman H, Payne J, Stempel A, Mohs K, Powers M, Yeh S, Smith J (2012). Imaging retinal vascular changes in the mouse model of oxygen-induced retinopathy. Translational Vision Science & Technology, 1(2), Article 5.

Raja H, Matteson E, Michet C, Smith J, Pulido J (2012). Safety of tumor necrosis factor inhibitors during pregnancy and breastfeeding. Translational Vision Science & Technology, 1(2), Article 6.